Probiotics and prebiotics in prevention and Treatment of diseases in infants and children;Probióticos e prebióticos na prevenção e no tratamento de doenças em lactentes e crianças

Jornal de Pediatria

Volumn 87, Issue 4, 2011, Pages 292-300

  Vandenplas, Yvan ^a   Veereman Wauters, Genevieve ^a   De Greef, Elisabeth ^a   Peeters, Stefaan ^b   Casteels, Ann ^c   Mahler, Tania ^a,d   Devreker, Thierry ^a   Hauser, Bruno ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b Algemeen Stedelijk Ziekenhuis   (Belgium)

^c Portaels Ziekenhuis   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Gastrointestinal flora; Intestinal microbiota; Oligosaccharide; Prebiotic; Probiotic

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

ATOPIC DERMATITIS; ATOPY; BREAST MILK; CHILDHOOD DISEASE; COLIC; CONSTIPATION; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; ENTERITIS; HELICOBACTER INFECTION; HUMAN; IMMUNE SYSTEM; INFANT DISEASE; INFECTION CONTROL; INFECTIOUS DIARRHEA; INTESTINE INFECTION; IRRITABLE COLON; MEDLINE; NECROTIZING COLITIS; REVIEW;

CHILD; DIARRHEA, INFANTILE; GASTROENTERITIS; HUMANS; INFANT; INFANT FORMULA; MILK, HUMAN; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS;

EID: 80051773329     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.2103     Document Type: Review

References (108)

1. Bartick M., Reinhold A. The burden of suboptimal breastfeeding in the United States: A pediatric cost analysis. Pediatrics. 2010;125:e1048-e1056
2. Vandenplas Y. Oligosaccharides in infant formula. Br J Nutr. 2002;87 Suppl 2:S293-S296 (Pubitemid 34685567)
3. Picciano M.F. Nutrient composition of human milk. Pediatr Clin North Am. 2001;48:53-67. (Pubitemid 32193127)
4. Coppa G.V., Zampini L., Galeazzi T., Gabrielli O. Prebiotics in human milk: A review. Dig Liver Dis. 2006;38 Suppl 2:S291-S294 (Pubitemid 46140772)
5. Zoetendal E.G., Vaughan E.E., De Vos W.M. A microbial world within us. Mol Microbiol. 2006;59:1639-1650
6. Thomas D.W., Greer F.R.; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126:1217-1231
7. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313-323
8. Harmsen H.J., Wildeboer-Veloo A.C., Raangs G.C., Wagendorp A.A., Klijn N., Bindels J.G., et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61-67 (Pubitemid 30349947)
9. Kleessen B., Bunke H., Tovar K., Noack J., Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr. 1995;84:1347-1356 (Pubitemid 26029955)
10. Penders J., Vink C., Driessen C., London N., Thijs C., Stobberingh E.E. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett. 2005;243:141-147 (Pubitemid 40164400)
11. Sakata S., Tonooka T., Ishizeki S., Takada M., Sakamoto M., Fukuyama M., et al. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiol Lett. 2005;243:417-423 (Pubitemid 40431209)
12. Satokari R.M., Vaughan E.E., Favier C.F., Doré J., Edwards C., De Vos W.M. Diversity of Bifidobacterium and Lactobacillus spp. in breastfed and formula-fed infants as assessed by 16S rDNA sequence differences. Microb Ecol Health Dis. 2002;14:97-105. (Pubitemid 34832423)
13. Rautava S., Ruuskanen O., Ouwehand A., Salminen S., Isolauri E. The hygiene hypothesis of atopic disease - an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378-388
14. Shadid R., Haarman M., Knol J., Theis W., Beermann C., Rjosk-Dendorfer D., et al. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity - a randomized, double-blind, placebo-controlled study. Am J Clin Nutr. 2007;86:1426-1437 (Pubitemid 350126248)
15. Heyman M.B.; Committee on Nutrition. Lactose intolerance in infants, children, and adolescents. Pediatrics. 2006;118:1279-1286
16. McClure R.J., Newell S.J. Randomized controlled study of digestive enzyme activity following trophic feeding. Acta Paediatr. 2002;91:292-296 (Pubitemid 34270867)
17. Quan R., Barness L.A. Do infants need nucleotide supplemented formula for optimal nutrition? J Pediatr Gastroenterol Nutr. 1990;11:429-434
18. Moro G., Minoli I., Mosca M., Fanaro S., Jelinek J., Stahl B., et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34:291-295 (Pubitemid 34437523)
19. Haarman M., Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005;71:2318-2324 (Pubitemid 40646972)
20. Scholtens P.A., Alliet P., Raes M., Alles M.S., Kroes H., Boehm G., et al. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr. 2008;138:1141-1147 (Pubitemid 351769142)
21. Falony G., Vlachou A., Verbrugghe K., De Vuyst L. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol. 2006;72:7835-7841 (Pubitemid 44927691)
22. Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics. 2005;115:5-9. (Pubitemid 43046274)
23. Szajewska H., Setty M., Mrukowicz J., Guandalini S. Probiotics in gastrointestinal diseases in children: Hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr. 2006;42:454-475 (Pubitemid 43804722)
24. Szajewska H., Mrukowicz J.Z. Use of probiotics in children with acute diarrhea. Paediatr Drugs. 2005;7:111-122 (Pubitemid 40733721)
25. Hojsak I., Abdović S., Szajewska H., Milosević M., Krznarić Z., Kolacek S. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 2010;125:e1171-e1177
26. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001;138:361-365 (Pubitemid 32207138)
27. Leyer G.J., Li S., Mubasher M.E., Reifer C., Ouwehand A.C. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 2009;124:e172-e179
28. Saran S., Gopalan S., Krishna T.P. Use of fermented foods to combat stunting and failure to thrive. Nutrition. 2002;18:393-396 (Pubitemid 34414968)
29. Sazawal S., Dhingra U., Sarkar A., Dhingra P., Deb S., Marwah D., et al. Efficacy of milk fortified with a probiotic Bifidobacterium lactis (DR-10TM) and prebiotic galacto-oligosaccharides in prevention of morbidity and on nutritional status. Asia Pac J Clin Nutr. 2004;13:S28.
30. Sur D., Manna B., Niyogi S.K., Ramamurthy T., Palit A., Nomoto K., et al. Role of probiotic in preventing acute diarrhoea in children: A community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiol Infect. 2010;30:1-8.
31. Szajewska H., Ruszczynski M., Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J Pediatr. 2006;149:367-372
32. Corrêa N.B., Péret Filho L.A., Penna F.J., Lima F.M., Nicoli J.R. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol. 2005;39:385-389 (Pubitemid 40548075)
33. Hawrelak J.A., Whitten D.L., Myers S.P. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: A systematic review. Digestion. 2005;72:51-56 (Pubitemid 41254156)
34. D'Souza A.L., Rajkumar C., Cooke J., Bulpitt C.J. Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ. 2002;324:1361.
35. Kale-Pradhan P.B., Jassal H.K., Wilhelm S.M. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: A meta-analysis. Pharmacotherapy. 2010;30:119-126
36. Johnston B.C., Supina A.L., Ospina M., Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2007:CD004827.
37. Kalliomäki M. Salminen S., Poussa T., Isolauri E. Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1019-1021 (Pubitemid 46527807)
38. Kalliomäki M., Antoine J.M., Herz U., Rijkers G.T., Wells J.M., Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: Prevention and management of allergic diseases by probiotics. J Nutr. 2010;140:713S-721S
39. Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121:116-121
40. Prescott S.L., Björkstén B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol. 2007;120:255-262 (Pubitemid 47102387)
41. Osborn D.A., Sinn J.K. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev. 2007:CD006475.
42. van der Aa LB, Heymans HS, van Aalderen WM, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol. 2010;21:e355-e367
43. Penders J., Stobberingh E.E., Van den Brandt P.A., Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy. 2007;62:1223-1236 (Pubitemid 47537504)
44. Alfaleh K., Anabrees J., Bassler D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: A meta-analysis. Neonatology. 2010;97:93-99
45. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999;3:197-202.
46. Braga T.D., da Silva G.A., De Lira P.I., De Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. Am J Clin Nutr. 2010;93:81-86
47. Luoto R., Matomäki J., Isolauri E., Lehtonen L. Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG. Acta Paediatr. 2010;99:1135-1138
48. Lin H.C., Su B.H., Chen A.C., Lin T.W., Tsai C.H., Yeh T.F., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115:1-4.
49. Lin H.C., Hsu C.H., Chen H.L., Chung M.Y., Hsu J.F., Lien R.I., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: A multicenter, randomized, controlled trial. Pediatrics. 2008;122:693-700.
50. Indrio F., Riezzo G., Raimondi F., Bisceglia M., Cavallo L., Francavilla R. Effects of probiotic and prebiotic on gastrointestinal motility in newborns. J Physiol Pharmacol. 2009;60 Suppl 6:27-31.
51. Indrio F., Riezzo G., Raimondi F., Bisceglia M., Filannino A., Cavallo L., et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest. 2011;41:417-422
52. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620-1633 (Pubitemid 38649878)
53. Guandalini S. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Rev Clin Immunol. 2010;6:47-54.
54. Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassano R.N., Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009;104:437-443
55. Westerbeek E.A., Van den Berg J.P., Lafeber H.N., Fetter W.P., Boehm G., Twisk J.W., et al. Neutral and acidic oligosaccharides in preterm infants: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2010;91:679-686
56. Moro G., Arslanoglu S., Stahl B., Jelinek J., Wahn U., Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814-819 (Pubitemid 44521163)
57. Arslanoglu S., Moro G.E., Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr. 2007;137:2420-2424 (Pubitemid 350058710)
58. Arslanoglu S., Moro G.E., Schmitt J., Tandoi L., Rizzardi S., Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138:1091-1095 (Pubitemid 351769134)
59. Bruzzese E., Volpicelli M., Squeglia V., Bruzzese D., Salvini F., Bisceglia M., et al. A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: An observational study. Clin Nutr. 2009;28:156-161
60. Scholtens P.A., Alliet P., Raes M., Alles M.S., Kroes H., Boehm G., et al. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr. 2008;138:1141-1147 (Pubitemid 351769142)
61. Raes M., Scholtens P.A., Alliet P., Hensen K., Jongen H., Boehm G., et al. Exploration of basal immune parameters in healthy infants receiving an infant milk formula supplemented with prebiotics. Pediatr Allergy Immunol. 2010;21:e377-e385
62. Sazawal S., Dhingra U., Hiremath G., Sarkar A., Dhingra P., Dutta A., et al. Prebiotic and probiotic fortified milk in prevention of morbidities among children: Community-based, randomized, double-blind, controlled trial. PLoS One. 2010;5:e12164.
63. Szajewska H., Setty M., Mrukowicz J., Guandalini S. Probiotics in gastrointestinal diseases in children: Hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr. 2006;42:454-475 (Pubitemid 43804722)
64. Kurugöl Z., Koturoǧlu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr. 2005;94:44-47 (Pubitemid 40127932)
65. Eren M., Dinleyici E.C., Vandenplas Y. Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: A randomized, controlled, open label study. Am J Trop Med Hyg. 2010;82:488-491
66. Guarino A., Lo Vecchio A., Canani R.B. Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol. 2009;25:18-23.
67. Szajewska H., Skórka A., Ruszczyński M., Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther. 2007;25:871-881 (Pubitemid 46525343)
68. Misra S., Sabui T.K., Pal N.K. A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea. J Pediatr. 2009;155:129-132
69. Ritchie B.K., Brewster D.R., Tran C.D., Davidson G.P., McNeil Y., Butler R.N. Efficacy of Lactobacillus GG in aboriginal children with acute diarrhoeal disease: A randomised clinical trial. J Pediatr Gastroenterol Nutr. 2010;50:619-624
70. Basu S., Paul D.K., Ganguly S., Chatterjee M., Chandra P.K. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: A randomized controlled trial. J Clin Gastroenterol. 2009;43:208-213
71. Szajewska H., Mrukowicz J.Z. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001;33 Suppl 2:S17-S25 (Pubitemid 33070120)
72. Van Niel C.W., Feudtner C., Garrison M.M., Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: A meta-analysis. Pediatrics. 2002;109:678-684 (Pubitemid 34286304)
73. Huang J.S., Bousvaros A., Lee J.W., Diaz A., Davidson E.J. Efficacy of probiotic use in acute diarrhea in children: A meta-analysis. Dig Dis Sci. 2002;47:2625-2634 (Pubitemid 35305477)
74. Allen S.J., Okoko B., Martinez E., Gregorio G., Dans L.F. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev. 2004:CD003048.
75. Dinleyici E.C., Eren M., Yargic Z.A., Dogan N., Vandenplas Y. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: A prospective, randomized, open label study. Am J Trop Med Hyg. 2009;80:953-955
76. Besirbellioglu B.A., Ulcay A., Can M., Erdem H., Tanyuksel M., Avci I.Y., et al. Saccharomyces boulardii and infection due to Giardia lamblia. Scand J Infect Dis. 2006;38:479-481 (Pubitemid 44150785)
77. Szajewska H., Skórka A. Saccharomyces boulardii for treating acute gastroenteritis in children: Updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther. 2009;30:960-961
78. Gutiérrez Castrellón P., Polanco Allué I., Salazar Lindo E An evidence based Iberic-Latin American guideline for acute gastroenteritis management in infants and prescholars An Pediatr (Barc) 2010;72:220.e1-220.e20.
79. Guarino A., Albano F., Ashkenazi S., Gendrel D., Hoekstra J.H., Shamir R., et al ESPGHAN/ESPID Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe Expert Working Group. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Executive summary. J Pediatr Gastroenterol Nutr. 2008;46:619-621
80. Rohde C.L., Bartolini V., Jones N. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. Nutr Clin Pract. 2009;24:33-40.
81. Sachdeva A., Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: A systematic review and meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol. 2009;21:45-53.
82. Sýkora J., Valecková K., Amlerová J., Siala K., Dedek P., Watkins S., et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: A prospective randomized double-blind study. J Clin Gastroenterol. 2005;39:692-698 (Pubitemid 41177089)
83. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., Murrell D.F., Tang M.L. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008:CD006135.
84. Van der Aa L.B., Heymans H.S., Van Aalderen W.M., Sillevis Smitt J.H., Knol J., Ben Amor K., et al; Synbad Study Group. Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomizedcontrolled trial. Clin Exp Allergy. 2010;40:795-804.
85. Rolfe V.E., Fortun P.J., Hawkey C.J., Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2006:CD004826.
86. Savino F., Pelle E., Palumeri E., Oggero R., Miniero R. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: A prospective randomized study. Pediatrics. 2007;119:e124-e130 (Pubitemid 46397815)
87. Savino F., Cordisco L., Tarasco V., Palumeri E., Calabrese R., Oggero R., et al. Lactobacillus reuteri DSM 17938 in infantile colic: A randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126:e526-e533
88. Elmer G.W., McFarland L.V., Surawicz C.M., Danko L., Greenberg R.N. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther. 1999;13:1663-1668 (Pubitemid 30009085)
89. Shornikova A.V., Casas I.A., Mykkänen H., Salo E., Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J. 1997;16:1103-1107 (Pubitemid 28006664)
90. Lewis S.J., Potts L.F., Barry R.E. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect. 1998;36:171-174 (Pubitemid 28165587)
91. Borchers A.T., Selmi C., Meyers F.J., Keen C.L., Gershwin M.E. Probiotics and immunity. J Gastroenterol. 2009;44:26-46.
92. Gill H.S., Rutherfurd K.J., Cross M.L., Gopal P.K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001;74:833-839 (Pubitemid 33101806)
93. Smits H.H., Engering A., Van der Kleij D., De Jong E.C., Schipper K., Van Capel T.M., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005;115:1260-1267 (Pubitemid 40824599)
94. Zhang L., Li N., Caicedo R., Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr. 2005;135:1752-1756 (Pubitemid 40980729)
95. Villarruel G., Rubio D.M., Lopez F., Cintioni J., Gurevech R., Romero G., et al. Saccharomyces boulardii in acute childhood diarrhoea: A randomized, placebo-controlled study. Acta Paediatr. 2007;96:538-541 (Pubitemid 46466118)
96. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Møller P.L., Tvede M., et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending daycare centers. Pediatr Infect Dis J. 2002;21:417-419 (Pubitemid 34532936)
97. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Møller P.L., Pedersen P., et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J. 2002;21:411-416 (Pubitemid 34532935)
98. Yuan Q., Walker W.A. Innate immunity of the gut: Mucosal defense in health and disease. J Pediatr Gastroenterol Nutr. 2004;38:463-473
99. Martín R., Heilig G.H., Zoetendal E.G., Smidt H., Rodríguez J.M. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol. 2007;103:2638-2644 (Pubitemid 350191191)
100. Perez P.F., Doré J., Leclerc M., Levenez F., Benyacoub J., Serrant P., et al. Bacterial imprinting of the neonatal immune system: Lessons from maternal cells? Pediatrics. 2007;119:e724-e732 (Pubitemid 46407547)
101. Kurugöl Z., Koturoǧlu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr. 2005;94:44-47 (Pubitemid 40127932)
102. Fedorak R.N., Madsen K.L. Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol. 2004;20:146-155 (Pubitemid 38297403)
103. Venugopalan V., Shriner K.A., Wong-Beringer A. Regulatory oversight and safety of probiotic use. Emerg Infect Dis. 2010;16:1661-1665
104. Vandenplas Y., Salvatore S., Vieira M., Devreker T., Hauser B. Probiotics in infectious diarrhoea in children: Are they indicated? Eur J Pediatr. 2007;166:1211-1218 (Pubitemid 350029481)
105. Oudhuis G.J., Bergmans D.C., Dormans T., Zwaveling J.H., Kessels A., Prins M.H., et al. Probiotics versus antibiotic decontamination of the digestive tract: Infection and mortality. Intensive Care Med. 2011;37:110-117
106. Besselink M.G., Van Santvoort H.C., Buskens E., Boermeester M.A., Van Goor H., Timmerman H.M., et al Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651-659
107. Moran J.P., Walter J., Tannock G.W., Tonkonogy S.L., Sartor R.B. Bif-idobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice. Inflamm Bowel Dis. 2009;15:1022-1031
108. Taylor A.L., Dunstan J.A., Prescott S.L. Probiotic supplementation for the first 6 months of life fail to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol. 2007;119:184-191 (Pubitemid 46037800)